In order to eliminate the suppressive effect of TGF-β in tumor environment, CAR T cells expressing the dominant-negative TGF-βRII demonstrate resistance to exhaustion and long-term persistence in prostate cancer mouse models [103]. The gene discussed is TGFB1; the disease is neoplasm.